title: More on normal prothrombin times in the presence of therapeutic levels of rivaroxaban--early experience from King's College Hospital.
authors.forename: Jignesh P
authors.initials: JP
authors.lastname: Patel
authors.forename: Lara N
authors.initials: LN
authors.lastname: Roberts
authors.forename: Paradzai B
authors.initials: PB
authors.lastname: Chitongo
authors.forename: Raj K
authors.initials: RK
authors.lastname: Patel
authors.forename: Roopen
authors.initials: R
authors.lastname: Arya
mesh_terms: D000925:Anticoagulants / Q000097:blood* / Q000627:therapeutic use*; D006801:Humans; D009025:Morpholines / Q000097:blood* / Q000627:therapeutic use*; D013876:Thiophenes / Q000097:blood* / Q000627:therapeutic use*; D020246:Venous Thrombosis / Q000097:blood* / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes
keywords: direct-Xa inhibitors; prothrombin time; rivaroxaban